Skip to content
Trial Eligibility
Menu

Functional Connectivity Alterations in Suicidal Patients Among Opioid Users

NCT05489042

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Suicide is the 10th leading cause of death for Americans of all ages and more people in the United States now die from suicide than die from car accidents. Although death by firearm remains the most common cause of suicide in the United States, an intentional overdose of substance usage such as prescription opioids accounts for over 5,000 suicides per year. In 2017, more than 70,000 drug overdose deaths occurred, making it the leading cause of injury-related death, and well over half (67.8%) involved opioids.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Substance Abuse
  • Suicide
  • Depression

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
18 to 64 years
Sex
All
Healthy volunteers
Accepted
Sponsor
Baylor College of Medicine
Last updated on ClinicalTrials.gov
April 4, 2025

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Texas · 1

  • The Menninger Clinic · Houston, TX

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.